Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115;
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115.
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E11988-E11995. doi: 10.1073/pnas.1810840115.
Bystander selection-the selective pressure for resistance exerted by antibiotics on microbes that are not the target pathogen of treatment-is critical to understanding the total impact of broad-spectrum antibiotic use on pathogenic bacterial species that are often carried asymptomatically. However, to our knowledge, this effect has never been quantified. We quantify bystander selection for resistance for a range of clinically relevant antibiotic-species pairs as the proportion of all antibiotic exposures received by a species for conditions in which that species was not the causative pathogen ("proportion of bystander exposures"). Data sources include the 2010-2011 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, the Human Microbiome Project, and additional carriage and etiological data from existing literature. For outpatient prescribing in the United States, we find that this proportion over all included antibiotic classes is over 80% for eight of nine organisms of interest. Low proportions of bystander exposure are often associated with infrequent bacterial carriage or concentrated prescribing of a particular antibiotic for conditions caused by the species of interest. Applying our results, we roughly estimate that pneumococcal conjugate vaccination programs result in nearly the same proportional reduction in total antibiotic exposures of , , and , despite the latter two organisms not being targeted by the vaccine. These results underscore the importance of considering antibiotic exposures of bystanders, in addition to the target pathogen, in measuring the impact of antibiotic resistance interventions.
旁观者选择——抗生素对治疗中并非目标病原体的微生物施加的抗性选择压力,对于理解广谱抗生素使用对通常无症状携带的致病细菌物种的总体影响至关重要。然而,据我们所知,这种影响从未被量化过。我们量化了一系列与临床相关的抗生素-物种对的抗性旁观者选择,其比例为该物种未成为致病病原体的情况下,该物种所接受的所有抗生素暴露的比例(“旁观者暴露比例”)。数据来源包括 2010-2011 年全国门诊医疗调查和全国医院门诊医疗调查、人类微生物组计划以及来自现有文献的额外携带和病因数据。对于美国的门诊处方,我们发现,对于所有包括的抗生素类别,在九个感兴趣的生物体中有八个的这一比例超过 80%。旁观者暴露的低比例通常与细菌携带频率低或特定抗生素集中用于该生物体引起的疾病有关。应用我们的结果,我们大致估计,尽管肺炎球菌结合疫苗并未针对后两种生物体,但其导致的肺炎球菌、流感嗜血杆菌和卡他莫拉菌的总抗生素暴露比例的减少大致相同。这些结果强调了在衡量抗生素耐药性干预措施的影响时,除了目标病原体之外,还需要考虑旁观者的抗生素暴露。